systemic non-biological treatments

DRUG2 trials

Sponsors

Janssen Biotech, Inc.

Conditions

Ankylosing SpondylitisArthritis, PsoriaticPsoriasisRheumatoid Arthritis

Unknown Phase

Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

CompletedNCT01081730

Janssen Biotech, Inc.Psoriasis

Start: 2010-02-09End: 2017-09-29Updated: 2025-06-25

Golimumab Safety and Surveillance Program Using the Ingenix NHI Database

CompletedNCT01081717

Janssen Biotech, Inc.Ankylosing Spondylitis, Arthritis, Psoriatic, Rheumatoid Arthritis

Start: 2009-04-14End: 2015-05-31Updated: 2025-06-25